Trial intelligence / Profile preview

Honey Dressing for Post-Surgical Site Infection Prevention

NCT06220344Phase 3Completed

Sponsor
HITEC Institute of Medical Sciences
Start
Dec 2022
Primary completion
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Revamil in surgical site infection (SSI), sponsored by HITEC Institute of Medical Sciences. Started Dec 2022; status: completed.

02

Drugs

Revamil
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT06220344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06220344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call